Quarter Period Consolidated Statement Of Income

株式会社PRISM BioLab - Filing #7262865

Concept 2024-10-01 to
2025-03-31
2023-10-01 to
2024-03-31
Quarter period consolidated statement of income
Statement of income
Net sales
218,676,000 JPY
115,482,000 JPY
Cost of sales
167,209,000 JPY
45,091,000 JPY
Gross profit (loss)
51,466,000 JPY
70,391,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
512,071,000 JPY
404,723,000 JPY
Operating profit (loss)
-460,605,000 JPY
-334,331,000 JPY
Non-operating income
Interest income
2,063,000 JPY
12,000 JPY
Non-operating income
28,342,000 JPY
16,726,000 JPY
Non-operating expenses
Non-operating expenses
113,000 JPY
5,250,000 JPY
Ordinary profit (loss)
-432,376,000 JPY
-322,855,000 JPY
Extraordinary losses
Impairment losses
40,800,000 JPY
12,593,000 JPY
Extraordinary losses
40,800,000 JPY
12,593,000 JPY
Profit (loss) before income taxes
-473,177,000 JPY
-335,448,000 JPY
Income taxes - current
1,210,000 JPY
604,000 JPY
Income taxes
1,210,000 JPY
604,000 JPY
Profit (loss)
-474,387,000 JPY
-336,052,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.